Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953173 · ClinicalTrials.gov registry record
HERO Study: Helping Evaluate Reduction in Obesity
A clinical trial of Obesity, sponsored by Apollo Endosurgery.
- Completed
- Registry status
- 671
- Enrollment target
- 6
- Study locations
NCT00953173: Completed study of Obesity, sponsored by Apollo Endosurgery.
NCT00953173 is a study of Obesity that has completed, run by Apollo Endosurgery. The registered enrollment target is 671 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00953173, a study of Obesity, has completed, sponsored by Apollo Endosurgery.
- COMPLETED
- Registry status
- 671 participants
- Enrollment target
- 6
- Study locations
Study Summary
A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
Primary Outcome
Percent of total body weight change.
Conditions Studied
Interventions
- DEVICE LAP-BAND AP® Adjustable Gastric Banding System
Study Locations (6)
Other
- - Jette
- - Naples
- - Birmingham
Washington
- - Everett
South Australia
- - Adelaide
Ontario
- - Mississauga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 671 participants |
| Start Date | 2009-12 |
| Est. Completion | 2016-10 |
What the finished NCT00953173 record still lists
NCT00953173 is an observational study that tracks outcomes without assigning an intervention. The registered 671 participants enrollment target is mid-sized for trials with a published cap, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which LAP-BAND AP® Adjustable Gastric Banding System is the first listed.
NCT00953173 lists 6 locations in 4 states (Other, Washington, South Australia).
Frequently Asked Questions
What is clinical trial NCT00953173 about?
NCT00953173 is a clinical study titled "HERO Study: Helping Evaluate Reduction in Obesity". A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
What is the current status of trial NCT00953173?
This trial is currently completed. The enrollment target is 671 participants. The study started on 2009-12. Estimated completion is 2016-10.
What conditions does trial NCT00953173 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00953173?
The interventions under investigation include: LAP-BAND AP® Adjustable Gastric Banding System (DEVICE).
Who is sponsoring clinical trial NCT00953173?
This trial is sponsored by Apollo Endosurgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00953173 being conducted?
This trial has 6 study locations across Washington, South Australia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00953173's enrollment target sits among peer trials
671 110th of 1053 higher than 944 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia